ITRM vs MCD · rev $390.0K vs P/E 23, rev $25.92B
Iterum Therapeutics PLC (ITRM) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
ITRM currently screens at market cap $38.6M. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the ITRM and MCD stock pages for the full models.
Not investment advice.